The overexpression of both EFNA1 and LIF is common in colorectal cancer and associated with poor patient outcomes, and LIF expression mediates chemoresistance via the negative regulation of p53 in vitro (78, 79). This evidence concerns the gene TP53 and colorectal cancer.